Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJacob P. Laubach, Paul G. Richardson, U-H Mellqvist et al.|Leukemia|2015Cited by 256
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMTDavid Buchbinder, Bronwen E. Shaw, Debra Lynch Kelly et al.|Bone Marrow Transplantation|2018Cited by 104
Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow TransplantationDebra Lynch Kelly, Bronwen E. Shaw, David Buchbinder et al.|Transplantation and Cellular Therapy|2017Cited by 65
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysisGabriel N. Mannis, Thomas G. Martin, Aaron C. Logan et al.|Bone Marrow Transplantation|2014Cited by 13
Long-Term Outcomes of 133 Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with High-Dose Chemotherapy and Autologous Stem Cell Rescue in First Complete RemissionGabriel N. Mannis, Charalambos Andreadis, Thomas Martin et al.|Transplantation and Cellular Therapy|2015Cited by 1